MedTrace Logo

Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders

NCT03294525 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-08-30

No results posted yet for this study

Summary

The project is a multi-center, prospective cohort study. The study's total targeted enrollment is 400 first-episode patients with major depressive disorder (MDD) and 400 healthy controls.

Conditions

  • Affective Disorder

Interventions

DRUG

Escitalopram Pill

escitalopram 10\~20mg/day

DRUG

Duloxetine

duloxetine 30\~120mg/day

DRUG

Mirtazapine Pill

Mirtazapine 15\~45mg/day

DRUG

Other Antidepressants

Sponsors & Collaborators

  • Peking University

    lead OTHER

Principal Investigators

  • Tianmei Si, PhD · Sixth hospital of beijing university

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2021-12-31
Completion
2022-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03294525 on ClinicalTrials.gov